Innovation Pharmaceuticals Inc (IPIX)

[Ernesto]

If the market knew that Kevetrin in Phase 1 has proven both efficacy and safety the stock would be much higher. We are waiting for confirmation. Dana Farber's Dr Shapiro saying it is what we want to hear.

We know that it is safe and efficacious. Orphan designation requires safety and some sort of efficacy. I don't think the official results will deviate from what can easily be deduced from the dosing and orphan designations. Regardless, Dana Farber will not have anything for us in 2015.

There is much more to come on Brilacidin Phase 3 and the same with Kevetrin Phase 2 ovarian cancer.

I certainly hope so or we're sunk. That will be in 2016 and beyond though. Neither is likely to be recruiting this year.

Infact if you look at the progression of all the trials CTIX has put together everyone of them has been a success. In other words we are looking at a major success story which can only transmit into a higher SP.

Indeed. More a question of when than if.

PS The company has already stated they want to be another Regeneron which to me means $$$$$ from many BPs.

We can all dream big. I'd love to be there asap.


The lack of new information makes this a very safe short into tax loss selling season as far as the odds go. I expect one last hit piece and bear raid pushing us to new lows prior to a glorious 2016.